DNA cytometry in breast cancer. Review of methods and its role in prognostic evaluation;DNA-Zytometrie beim Mammakarzinom. Ubersicht zur Methode und zum Stellenwert bei der Prognoseabschatzung

Pathologe

Volumn 18, Issue 1, 1997, Pages 19-26

  Sinn, H P ^a   Haag, D ^a   Ehemann, V ^a   Magener, A ^a   Goerttler, K ^a   Bastert, G ^b   Otto, H F ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

breast cancer; DNA flow cytometry; prognosis

Indexed keywords

BREAST CARCINOMA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; PROGNOSIS; REVIEW;

BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL DIVISION; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; PLOIDIES; PROGNOSIS; S PHASE;

EID: 0030978684     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002920050192     Document Type: Review

References (82)

1. Aaltomaa S, Lipponen P, Syrjanen K (1993) Nucleolar organizer regions related to morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis in female breast cancer. Pathol Res Pract 189: 416-421
2. Altman DG, Lausen B, Sauerbrei W, Schumacher M (1994) Dangers of using "opti-mal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86: 829-835
3. Aubele M, Auer G, Jutting U, Falkmer U, Gais P (1994) Prognostic value of quantitatively measured AgNORs in ductal mammary carcinoma. Anal Quant Cytol Histol 16: 211-218
4. Auer G, Eriksson E, Azavedo E, Caspersson T, Wallgren A (1984) Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans. Cancer Res 44: 394-396
5. Auer GU, Caspersson TO, Wallgren AS (1980) DNA content and survival in mammary carcinoma. Anal Quant Cytol Histol 2: 161-165
6. Baldetorp B, Ferno M, Fallenius A, Falle nius Vecchi G, Idvall I, Olsson H, Sigurdsson H, Akerman M, Killander D (1992) Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry. Cytometry 13: 577-585
7. Berryman IL, Harvey JM, Sterrett GF, Papadimitriou JM (1987) The nuclear DNA content of human breast carcinoma. Associations with clinical stage, axillary lymph node status, estrogen receptor status and outcome. Anal Quant Cytol Histol 9: 429-434
8. Biesterfeld S, Noll I, Noll E, Wohltmann D, Bocking A (1995) Mitotic frequency as a prognostic factor in breast cancer. Hum Pathol 26: 47-52
9. Bilous AM, McKay M, Milliken J (1991) A comparison between Ki-67 antibody reactivity and other pathological variables in breast carcinoma. Pathology 23: 282-285
10. Borgiani L, Cogorno P, Oliviero J, Toso F, Gambini G, Tunesi G, Canepa M (1994) AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry. Eur J Histochem 38: 171-176
11. Bosari S, Lee AK, Tahan SR, Figoni MA, Wiley BD, Heatley GJ, Silverman ML (1992) DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma. Cancer 70: 1943-1950
12. Böcking A, Chatelain R, Biesterfeld S, Noll E, Biesterfeld D, Wohtmann D, Goecke G (1989) DNA grading of malignancy in breast cancer: prognostic validity reproducibility and comparison with other classification. Anal Quant Cytol Histol 11: 73-80
13. Böhm N, Sprenger E, Sandritter W (1971) Fluorescence cytophotometric Feulgen-DNA measurements of benign and malignant human tumors. Beitr Pathol 142: 210-220
14. Briffod M, Spyratos F, Hacene K, Tubiana Hulin M, Pallud C, Gilles F, Rouesse J (1992) Evaluation of breast carcinoma chemosensitivity by flow cytometric DNA analysis and computer assisted image analysis. Cytometry 13: 250-258
15. Caspersson T (1936) Über den chemischen Aufbau der Strukturen des Zellkerns. Skand Arch Physiol 73 [Suppl]: 1-23
16. Chevillard S, Fouillait P, Beldjord C, Asselain B, Beuzeboc P, Magdelenat H, Vielh P (1996) Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy. Cancer 77: 292-300
17. Clark GM, Dressler LG, Owens MA, Pounds G, Oldaker T, McGuire WL (1989) Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 320: 627-633
18. Clark JS, George WD, Campbell AM (1992) Dual colour flow cytometry of p53 and c-erbB-2 expression related to DNA aneuploidy in primary and metastatic breast cancer. Cancer Lett 66: 193-200
19. Clayton F (1991) Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor. Cancer 68: 1309-1317
20. Cornelisse CJ, Velde CJ van de, Caspers RJ, Moolenaar AJ, Hermans J (1987) DNA ploidy and survival in breast cancer patients. Cytometry 8: 225-234
21. Daidone MG, Silvestrini R, Luisi A, Mastore M, Benini E, Veneroni S, Brambilla C, Ferrari L, Greco M, Andreola S et al. (1995) Changes in biological markers after primary chemotherapy for breast cancers. Int J Cancer 61: 301-305
22. Dawson AE, Norton JA, Weinberg DS (1990) Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. Am J Pathol 136: 1115-1124
23. Donegan WL (1992) Prognostic factors. Stage and receptor status in breast cancer. Cancer 70: 1755-1764
24. Dressler LG (1990) Controls, standards, and histogram interpretation in DNA flow cytometry. Methods Cell Biol 33: 157-171
25. Dressier LG, Eudey L, Gray R, Tormey DC, McGuire WL, Gilchrist KW, Clark GM, Osborne CK, Mansour EG, Abeloff MD (1992) Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: preliminary analysis of an intergroup study (INT 0076). Monogr Natl Cancer Inst 11: 167-172
26. Dressier LG, Seamer L, Owens MA, Clark GM, McGuire WL (1987) Evaluation of a modeling system for S-phase estimation in breast cancer by flow cytometry. Cancer Res 47: 5294-5302
27. Dressier LG, Seamer LC, Owens MA, Clark GM, McGuire WL (1988) DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 61: 420-427
28. Endresen PC, Prytz PS, Aarbakke J (1995) A new flow cytometric method for discrimination of apoptotic cells and detection of their cell cycle specificity through staining of F-actin and DNA. Cytometry 20: 162-171
29. Eskelinen MJ, Pajarinen P, Collan Y, Pesonen E, Alhava E, Kettunen K, Nordling S (1989) Relationship between DNA ploidy and survival in patients with primary breast cancer. Br J Surg 76: 830-834
30. Fallenius AG, Franzen SA, Auer GU (1988) Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. A retrospective study of 227 consecutive cases. Cancer 62: 521-530
31. Feichter GE (1991) Flow cytometry of breast cancer. Zentralbl Pathol 137: 220-226
32. Feichter GE, Goerttler K (1986) Pitfalls in the preparation of nuclear suspensions from paraffin-embedded tissue for flow cytometry [letter]. Cytometry 7: 616
33. Feichter GE, Muller A, Kaufmann M, Haag D, Born IA, Abel U, Klinga K, Kubli F, Goerttler K (1988) Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer. Int J Cancer 41: 823-828
34. Fisher ER, Anderson S, Redmond C, Fisher B (1993) Pathologic findings from the National surgical adjuvant breast project protocol B-06. 10-year pathologic and clinical prognostic discriminants. Cancer 71: 2507-2514
35. Frierson HF Jr (1988) Flow cytometric analysis of ploidy in solid neoplasms: comparison of fresh tissues with formalin-fixed paraffin-embedded specimens. Hum Pathol 19: 290-294
36. Frierson HFJ (1991) Ploidy analysis and S-phase fraction determination by flow cytometry of invasive adenocarcinomas of the breast. Am J Surg Pathol 15: 358-367
37. Gasparini G, Boracchi P, Verderio P, Bevilacqua P (1994) Cell kinetics in human breast cancer: comparison between the prognostic value of the cytofluorimetric S-phase fraction and that of the antibodies to Ki-67 and PCNA antigens detected by immunocytochemistry. Int J Cancer 57: 822-829
38. Gnant MF, Blijham G, Reiner A, Reiner G, Reynders M, Schutte B, Asche C van, Steger G, Jakesz R (1992) DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised study. Eur J Cancer 28: 711-716
39. Goerttler K (1990) Durchflusszytometrische Untersuchungen zum Proliferationsverhalten menschlicher Tumoren. Acta Histochem [Suppl] 39: 49-60
40. Göhde W, Us-Krasovec M, Pogacnik A (1995) Die Bedeutung der Messgenauigkeit bei der DNS-Zytophotometrie. Verh Dtsch Ges Zyt 19: 156-170
41. Haag D, Feichter G, Goerttler K, Kaufmann M (1987) Influence of systematic errors on the evaluation of the S phase portions from DNA distributions of solid tumors as shown for 328 breast carcinomas. Cytometry 8: 377-385
42. Haag D, Goerttler K, Tschahargane C (1984) The proliferative index (PI) of human breast cancer as obtained by flow cytometry. Pathol Res Pract 178: 315-322
43. Hedley DW (1989) Flow cytometry using paraffin-embedded tissue: five years on. Cytometry 10: 229-241
44. Hedley DW (1993) DNA cytometry consensus conference. DNA flow cytometry and breast cancer. Breast Cancer Res Treat 28: 51-53
45. Hedley DW, Clark GM, Cornelisse CJ, Killander D, Kute T, Merkel D (1993) DNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Breast Cancer Res Treat 28: 55-59
46. Hedley DW, Rugg CA, Gelber RD (1987) Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. Cancer Res 47: 4729-4735
47. Henson DE, Ries L, Freedman LS, Carriaga M (1991) Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer 68: 2142-2149
48. Hofstädter E, Knüchel R, Rüschoff J (1995) Cell proliferation assessment in oncology. Virchows Arch 427: 323-341
49. Hotz MA, Gong J, Traganos F, Darzynkiewicz Z (1994) Flow cytometric detection of apoptosis: comparison of the assays of in situ DNA degradation and chromatin changes. Cytometry 15: 237-244
50. Isola JJ, Helin HJ, Helle MJ, and Kallioniemi OP (1990) Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count. Cancer 65: 1180-1184
51. Kallioniemi OP (1988) Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Cytometry 9: 164-169
52. Kallioniemi OP, Blanco G, Alavaikko M, Hietanen T, Mattila J, Lauslahti K, Koivula T (1987) Tumour DNA ploidy as an independent prognostic factor in breast cancer. Br J Cancer 56: 637-642
53. Kaufmann M, Feichter GE, Nhila A, Klinga K, Abel U (1988) Flow-zytophotometrische Parameter, Hormonrezeptoren und axillarer Lymphknotenstatus als Prognosefaktoren beim primären Mammakarzinom. Geburtshilfe Frauenheilkd 48: 705-709
54. Keshgegian AA, Cnaan A (1995) Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1. Am J Clin Pathol 104: 42-49
55. Klintenberg C, Wallgren A, Bjelkenkrantz K, Carstenssen J, Humla S, Nordenskjold B, Skoog L (1985) DNA distribution, cytosol estrogen receptors and axillary nodes as prognostic predictors in breast carcinoma. Acta Radiol Oncol 24: 253-258
56. Knüchel R (1994) Durchflusszytometrische Analytik und Zellsortierung. Stand-ortbericht und Perspektiven für die Pathologie. Pathologe 15: 85-95
57. Koester SK, Maenpaa JU, Wiebe VJ, Baker WJ, Würz GT, Seymour RC, Koehler RE, DeGregorio MW (1994) Flow cytometry: potential utility in monitoring drug effects in breast cancer. Breast Cancer Res Treat 32: 57-65
58. Lewis WE (1990) Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients. Cancer 65: 2315-2320
59. Mansour EG, Ravdin PM, Dressler L (1994) Prognostic factors in early breast carcinoma. Cancer 74: 381-400
60. Merkel DE, Winchester DJ, Goldschmidt RA, August CZ, Wruck DM, Rademaker AW (1993) DNA flow cytometry and pathologic grading as prognostic guides in axillary lymph node-negative breast cancer. Cancer 72: 1926-1932
61. Meyer JS, Province MA (1994) S-phase fraction and nuclear size in long term prognosis of patients with breast cancer. Cancer 74: 2287-2299
62. Mitze M, Weikel W, Brumm C, Lippold R, Knapstein PG (1995) Einfluss der Proliferationsrate auf den Krankheitsverlauf von nodalnegativen Mammakarzinomen. Geburtshilfe Frauenheilkd 55: 299-305
63. Mourad WA, Erkman Baus B, Livingston S, Shoukri M, Cox CE, Nicosia SV, Rowlands DTJ (1992) Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with DNA flow cytometry, histopathology, and lymph node status. Cancer 69: 1739-1744
64. Muss HB, Kute TE, Case LD, Smith LR, Booher C, Long R, Kammire L, Gregory B, Brockschmidt JK (1989) The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer. Cancer 64: 1894-1900
65. Ottestad L, Pettersen EO, Nesland JM, Hannisdal E, Fossa SD, Tveit KM (1993) Flow cytometric DNA analysis as prognostic factor in human breast carcinoma. Pathol Res Pract 189: 405-410
66. Owainati AA, Robins RA, Hinton C, Ellis IO, Dowle CS, Ferry B, Elston CW, Blarney RW, Baldwin RW (1987) Tumour aneuploidy, prognostic parameters and survival in primary breast cancer. Br J Cancer 55: 449-454
67. Ravdin PM, Clark GM, Hough JJ, Owens MA, McGuire WL (1993) Neural network analysis of DNA flow cytometry histograms. Cytometry 14: 74-80
68. 67a. Remvikos Y, Gerbault Seurreau M, Vielh P, Zafrani B, Magdelenat H, Dutrillaux B (1988) Relevance of DNA ploidy as a measure of genetic deviation: a comparison of flow cytometry and cytogenetics in 25 cases of human breast cancer. Cytometry 9: 612-618
69. Remvikos Y, Jouve M, Beuzeboc P, Viehl P, Magdelenat H, Pouillart P (1993) Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspirates. Eur J Cancer 29A: 1843-1848
70. Sandritter W, Kiefer G, Kiefer R, Salm R, Moore GW, Grimm H (1974) DNA in heterochromatin cytophotometric pattern rec-ognition image analysis among cell nuclei in duct epithelium and in carcinoma of the human breast. Beitr Pathol 151: 87-96
71. Schmid I, Uittenbogaart CH, Giorgi JV (1994) Sensitive method for measuring apoptosis and cell surface phenotype in human thymocytes by flow cytometry. Cytometry 15: 12-20
72. Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Ferno M, Killander D, Olsson H, Ranstam J (1990) Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels. Br J Cancer 62: 786-790
73. Siitonen SM, Kallioniemi OP, Isola JJ (1993) Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer. Am J Pathol 142: 1081-1089
74. Stanton PD, Cooke TG, Oakes SJ, Winstanley J, Holt S, George WD, Murray GD (1992) Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer. Br J Cancer 66: 925-929
75. Tagawa Y, Nakazaki T, Yasutake T, Matsuo S, Tomita M (1993) Comparison of pepsin and trypsin digestion on paraffin-embedded tissue preparation for DNA flow cytometry. Cytometry 14: 541-549
76. Toikkanen S, Joensuu H, Klemi P (1989) The prognostic significance of nuclear DNA content in invasive breast cancer - a study with long-term follow-up. Br J Cancer 60: 693-700
77. Van Diest PJ, Matze Cok E, Baak JP (1991) Prognostic value of proliferative activity in lymph node metastases of patients with breast cancer. J Clin Pathol 44: 416-418
78. Visscher DW, Zarbo RJ, Jacobsen G, Kambouris A, Talpos G, Sakr W, Crissman JD (1990) Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations. Lab Invest 62: 370-378
79. Wersto RP, Stetler Stevenson M (1995) Debris compensation of DNA histograms and its effect on S-phase analysis. Cytometry 20: 43-52
80. Wingren S, Stal O, Nordenskjold B (1994) Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin. South East Sweden Breast Cancer Group. Br J Cancer 69: 546-549
81. Witzig TE, Ingle JN, Cha SS, Schaid DJ, Tabery RL, Wold LE, Grant C, Gonchoroff NJ, Katzmann JA (1994) DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer. Cancer 74: 1752-1761
82. Yoshida Y, Okamura T, Yano K, Kodate M, Oyama T, Inutsuka K, Taga S, Ezaki T (1994) A clinicopathological evaluation of nucleolar organizer region proteins in human breast carcinoma. Surg Oncol 3: 53-57